Proteomics,Multiomics

Dataset Information

0

The immunopeptidomic landscape of ovarian carcinoma


ABSTRACT: Immunopeptidome analysis of ovarian carcinoma tissues was performed to characterize the HLA class I and class II presented ligandome of this malignancy.

OTHER RELATED OMICS DATASETS IN: PRJNA398141

INSTRUMENT(S): LTQ Orbitrap

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Epithelial Cell, Ovarian Serous Carcinoma Cell

DISEASE(S): Malignant Neoplasm Of Ovary

SUBMITTER: Heiko Schuster  

LAB HEAD: Hans-Georg Rammensee

PROVIDER: PXD007635 | Pride | 2017-11-02

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
OvCa100_classII_Rep1.msf Msf
OvCa100_classII_Rep1.raw Raw
OvCa100_classII_Rep2.msf Msf
OvCa100_classII_Rep2.raw Raw
OvCa100_classII_Rep3.msf Msf
Items per page:
1 - 5 of 550
altmetric image

Publications


Immunotherapies, particularly checkpoint inhibitors, have set off a revolution in cancer therapy by releasing the power of the immune system. However, only little is known about the antigens that are essentially presented on cancer cells, capable of exposing them to immune cells. Large-scale HLA ligandome analysis has enabled us to exhaustively characterize the immunopeptidomic landscape of epithelial ovarian cancers (EOCs). Additional comparative profiling with the immunopeptidome of a variety  ...[more]

Similar Datasets

2018-12-11 | PXD010450 | Pride
2021-09-10 | PXD024871 | Pride
2022-07-19 | PXD035324 | Pride
2018-03-01 | PXD008937 | Pride
2022-09-22 | PXD024417 | Pride
2022-05-31 | PXD033935 | Pride
2019-12-11 | PXD015947 | Pride
2020-12-01 | PXD019258 | Pride
2023-07-05 | PXD041804 | Pride
2024-11-08 | PXD054248 | Pride